Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DX25F6XUK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,678.70 on September 24, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order calls for the supply of Nucala 100 mg/ml auto-injector units, with an ultimate completion date of September 25, 2025. This award was issued without a set-aside designation, allowing the vendor to compete on an open basis leveraging its small business status. The place of performance is Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facility medical supply needs. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of defense contracts covering branded and generic prescription drugs, biologics, and specialized medical products including auto-injectors and oncology treatments for Department of Defense healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6XUK?
SPE2DX25F6XUK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 24, 2025.
How much is contract SPE2DX25F6XUK worth?
The government has obligated $5,679 on SPE2DX25F6XUK.
Is contract SPE2DX25F6XUK an order under another contract?
Yes. SPE2DX25F6XUK is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XUK competed?
The extent of competition for SPE2DX25F6XUK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award